Law360, New York (October 01, 2010, 6:17 PM ET) -- The judge overseeing Hoffmann-La Roche Ltd.'s suits against Apotex Inc. and Cobalt Pharmaceuticals Inc.'s over planned generic versions of bone loss prevention treatment Boniva has ruled that a jury must decide whether the plaintiff engaged in inequitable conduct when procuring a patent for the drug.
Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey on Thursday denied cross-motions for summary judgment on the defendants' affirmative defense of inequitable conduct, finding that the claim rests on factual disputes.
According to Judge...
Jury To Decide Roche Battle Over Generic Boniva
To view the full article, take a free trial now.
